Jeanmarie Guenot

Chief Executive Officer, Chief Financial Officer, Secretary & Director at Amphivena Therapeutics, Inc.

Jeanmarie Guenot

Jeanmarie Guenot

Chief Executive Officer, Chief Financial Officer, Secretary & Director at Amphivena Therapeutics, Inc.

Overview
Career Highlights

Amphivena Therapeutics, Inc.
Harpoon Therapeutics, Inc.

RelSci Relationships

415

Number of Boards

2

Relationships
RelSci Relationships are individuals Jeanmarie Guenot likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Mpm Capital LLC

Relationship likelihood: Strong

Senior Vice President, Research & Development at Biocision LLC

Relationship likelihood: Strong

Chief Executive Officer at Affimed NV

Relationship likelihood: Strong

Managing Director at EMBL Ventures GmbH

Relationship likelihood: Strong

Senior Vice President, Research at Tekla Healthcare Investors

Relationship likelihood: Strong

Chief Financial Officer at Affimed NV

Relationship likelihood: Strong

Professional at Mpm Capital LLC

Relationship likelihood: Strong

Partner at Ophthalmic Consultants of Long Island

Relationship likelihood: Strong

Partner at Qiming Venture Partners Ltd.

Relationship likelihood: Strong

Chief Scientific Officer at Amphivena Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Jeanmarie Guenot
Potential Connections via
Relationship Science
You
Jeanmarie Guenot
Chief Executive Officer, Chief Financial Officer, Secretary & Director at Amphivena Therapeutics, Inc.
Education

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Career History
Chief Executive Officer, Chief Financial Officer, Secretary & Director
Current

Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm's' lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA.

Founder
2015 - Prior

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which develops a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. It offers Tri-specific T cell Activating Construct (TriTACs) that focuses on the treatment of solid tumors and hematologic malignancies. The company founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.

Vice President-Corporate & Business Development
2003 - Prior

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. The Pharmaceutical segment covers revenues from branded prescription medicine products being sold under the name Tekturna and Tekturna HCT in the United States, and Rasilez and Rasilez HCT for the rest of the world. The Medical Devices segment handles revenues from the LENSAR Laser System sales. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Transactions
Details Hidden

Amphivena Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Amphivena Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Amphivena Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which develops a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. It offers Tri-specific T cell Activating Construct (TriTACs) that focuses on the treatment of solid tumors and hematologic malignancies. The company founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jeanmarie Guenot. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jeanmarie Guenot's profile does not indicate a business or promotional relationship of any kind between RelSci and Jeanmarie Guenot.